Rajinder Paul Singh

Title: Rajinder Singh: Master of Innovation in Immunomodulation

Introduction:

Rajinder Singh, an accomplished inventor hailing from Belmont, CA, has made remarkable contributions to the field of immunomodulation through his extensive patent portfolio. With an impressive track record of 324 patents, he has brought forth groundbreaking compounds that exhibit potential in the field of immunotherapy. This article delves into Singh's latest patents, career highlights, collaborations, and his invaluable contributions to the field of pharmaceutical sciences.

Latest Patents:

Singh's recent patents demonstrate his dedication to the development of immunomodulator compounds. One significant patent titled "Indane-amines as PD-L1 antagonists" introduces compounds that can serve as immunomodulators. These compounds possess the formula (I), including stereoisomers and pharmaceutically acceptable salts. The patent also reveals methods related to the preparation and use of such compounds, along with pharmaceutical compositions comprising such agents.

Another notable patent addresses "Immunomodulator compounds" that hold promising potential for immunomodulatory purposes. Singh's patent discloses compounds with the formula (I), including stereoisomers and pharmaceutically acceptable salts, which can be utilized as immunomodulators. Furthermore, the patent covers methods associated with their preparation and use, as well as the development of pharmaceutical compositions that incorporate these compounds.

Career Highlights:

Throughout his career, Rajinder Singh has made significant contributions to the pharmaceutical industry. He has collaborated with renowned companies such as Rigel Pharmaceuticals, Incorporated, and Chemocentryx, Inc. These collaborations have provided Singh with invaluable industry experience and facilitated the process of transforming his inventions into practical applications.

Collaborations:

Singh's collaborations with fellow innovators have played a crucial role in his success. Notably, he has worked alongside remarkable individuals such as Hui Li and Somasekhar Bhamidipati. These collaborations have fostered an environment of collective creativity, enabling the development of groundbreaking patentable inventions in the field of immunomodulation.

Conclusion:

Rajinder Singh's patent portfolio reflects his unwavering commitment to the advancement of immunomodulation. Through his groundbreaking compounds and innovative methods, Singh has offered new avenues for exploring the possibilities of immunotherapy. His collaborations with esteemed companies and fellow professionals have further fueled his success, solidifying his position as a master innovator in his field. Rajinder Singh's contributions have undoubtedly propelled the field of immunomodulation to new heights, offering hope for future advancements in the treatment of various diseases.